Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease

NCT02209792 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Placebo
DRUG: BIBR 796 BS, 5 mg
DRUG: BIBR 796 BS, 20 mg

Sponsor

Boehringer Ingelheim